NIH-funded research R01 grant

Understanding how brain circuits respond to opioid relapse

Official title: Integrative single-cell spatial transcriptomic, anatomical, and functional profiling of brain-wide ensembles engaged by opioid relapse

Funded at University of Washington · NIH-10931509 · Data updated 2026-11-12

This study is looking at how the brain works when someone relapses on opioids, especially fentanyl, by testing mice to see how different brain cells and circuits might make some people more likely to struggle with addiction, which could help us understand why some people find it harder to stay off opioids.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 30, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$790,368
NIH project number5R01DA059374-02
Project IDNIH-10931509 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of opioid use or those at risk of opioid addiction.

Less likely to help

Patients who have never used opioids or are not at risk for opioid addiction may not benefit from this research.

What this research studies

This research investigates the brain mechanisms involved in opioid relapse, particularly focusing on the synthetic opioid fentanyl. By using advanced techniques like single-cell spatial transcriptomics and brain-wide neural activity recordings, the study aims to identify specific brain circuits and cell types that contribute to vulnerability in opioid use and abuse. The research will involve behavioral assessments in mice to understand how different individuals may respond to fentanyl, providing insights into the biological factors that influence addiction. This approach could lead to a better understanding of the genetic and functional changes in the brain associated with opioid relapse.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing and treating opioid addiction.

How similar studies have gone: Other research has shown promise in understanding addiction through similar advanced neurobiological approaches, indicating potential for success in this area.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Golden, Sam — University of Washington
  • Study coordinator: Golden, Sam

Related research

Other NIH-funded projects on the same topics.

  • Social stress and smoking: why disadvantaged young adults struggle to quit

    This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11540695

  • Learning from remission and relapse in lupus (SLE)

    Researchers are studying people with systemic lupus erythematosus who are in long-term remission without steroids or immunosuppressants to understand their immune cells, brain function, and what might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513534

  • Learning from Remission and Relapse in SLE

    A program to study people with systemic lupus erythematosus who are in long-term remission to understand immune and brain signals that might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513533

  • Alternative NF-kB activation after chemotherapy in ovarian cancer

    This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.

    NIH research San Diego State University · San Diego, United States · NIH-11473227

  • Predictors of autoimmunity onset and relapse in skin

    A study to understand what biological signals in skin predict when autoimmune diseases start, flare, or worsen in people at risk.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11471389

  • Determinants of TB Control, Relapse, and Reinfection

    A large, multi-year study aims to understand why some people who are treated for TB still have persistent infection or relapse, with the goal of improving prevention and treatment.

    NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11449646

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.